Breakdown | |||||
TTM | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
197.65M | 210.02M | 224.06M | 179.13M | 121.11M | 122.20M | Gross Profit |
149.50M | 131.94M | 122.74M | 94.60M | 93.32M | 91.51M | EBIT |
-103.18M | -91.36M | 17.01M | 17.72M | 19.92M | 31.93M | EBITDA |
-154.57M | -68.77M | 22.12M | 30.59M | 25.06M | 32.83M | Net Income Common Stockholders |
-110.38M | -99.65M | 18.20M | 12.40M | 18.16M | 21.92M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
56.61M | 56.61M | 87.92M | 118.48M | 129.19M | 118.33M | Total Assets |
436.44M | 436.44M | 581.99M | 507.61M | 362.92M | 297.09M | Total Debt |
163.99M | 163.99M | 149.56M | 137.71M | 158.45M | 107.77M | Net Debt |
120.62M | 120.62M | 88.46M | 59.38M | 62.41M | 22.57M | Total Liabilities |
268.72M | 268.72M | 273.14M | 235.21M | 227.76M | 179.35M | Stockholders Equity |
167.81M | 167.81M | 308.75M | 272.33M | 134.83M | 117.15M |
Cash Flow | Free Cash Flow | ||||
15.98M | -23.99M | -28.07M | 13.32M | 9.12M | 7.33M | Operating Cash Flow |
21.06M | -6.79M | -10.47M | 29.82M | 16.06M | 10.70M | Investing Cash Flow |
5.77M | -9.99M | -22.14M | -136.76M | -54.84M | -81.48M | Financing Cash Flow |
-33.53M | -3.07M | 14.39M | 88.37M | 50.13M | 116.67M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
66 Neutral | $4.48B | 12.26 | 5.32% | 248.53% | 4.10% | -12.36% | |
54 Neutral | €316.43M | ― | ― | -1.20% | ― | ||
€2.78B | 14.51 | 8.74% | 5.38% | ― | ― | ||
€905.42M | 111.21 | -10.16% | 1.74% | ― | ― | ||
€412.29M | 24.69 | 12.73% | 0.72% | ― | ― | ||
€438.96M | 43.69 | 25.87% | 1.91% | ― | ― | ||
€98.64M | 27.49 | ― | ― | ― |
Antares Vision Group has introduced AI-GO, an advanced artificial intelligence platform designed to revolutionize visual inspection in the pharmaceutical and manufacturing sectors. AI-GO enhances quality control by identifying complex anomalies and reducing false rejects, thereby improving production efficiency and product quality. This innovation positions Antares Vision Group as a leader in integrating AI into industrial processes, offering a system that learns and adapts to evolving production needs, ultimately supporting smarter and more sustainable manufacturing practices.
The most recent analyst rating on (IT:AV) stock is a Buy with a EUR4.60 price target. To see the full list of analyst forecasts on Antares Vision SpA stock, see the IT:AV Stock Forecast page.
Antares Vision S.p.A. announced the expiration of a shareholders’ agreement originally signed in 2020, which coordinated the exercise of shareholder rights in Regolo S.p.A., the controlling company of Antares Vision. The termination of this agreement may impact the governance system of Antares Vision, as it previously allowed parties to exercise specific governance prerogatives.
The most recent analyst rating on (IT:AV) stock is a Buy with a EUR4.00 price target. To see the full list of analyst forecasts on Antares Vision SpA stock, see the IT:AV Stock Forecast page.
Antares Vision S.p.A. has announced the publication of the minutes from its Ordinary and Extraordinary Shareholders’ Meeting held on May 7, 2025. This publication, in compliance with current regulations, is accessible at the company’s headquarters, on its website, and through the authorized storage mechanism ‘1INFO’.
The most recent analyst rating on (IT:AV) stock is a Buy with a EUR4.00 price target. To see the full list of analyst forecasts on Antares Vision SpA stock, see the IT:AV Stock Forecast page.
Antares Vision S.p.A. has updated its Bylaws following the Ordinary and Extraordinary Shareholders’ Meeting held on May 7, 2025. The updated Bylaws are now available at the company’s headquarters, on its website, and through the authorized storage mechanism ‘1INFO’. This update reflects the company’s commitment to maintaining transparency and compliance with current regulations, potentially impacting its governance and operational framework.
The most recent analyst rating on (IT:AV) stock is a Buy with a EUR4.00 price target. To see the full list of analyst forecasts on Antares Vision SpA stock, see the IT:AV Stock Forecast page.
Antares Vision Group is partnering with Guinea-Bissau to advance the digital transformation of its national health system, focusing on pharmaceutical traceability and safety. This collaboration aims to establish a digital healthcare ecosystem in West Africa, enhancing transparency and reliability in the pharmaceutical supply chain, and potentially setting a new standard for the region.
The most recent analyst rating on (IT:AV) stock is a Buy with a EUR4.00 price target. To see the full list of analyst forecasts on Antares Vision SpA stock, see the IT:AV Stock Forecast page.
Antares Vision S.p.A. held its Ordinary and Extraordinary Shareholders’ Meeting, where several key resolutions were approved, including the financial statements for 2024, a new long-term incentive plan, and capital increases for share-based incentive plans. Despite a reported loss, the company showed significant improvements in its operating margins and a reduction in labor costs, indicating a strategic focus on enhancing financial stability and operational efficiency. These developments are expected to strengthen Antares Vision’s market position and provide value to stakeholders.
Antares Vision S.p.A. has made available its annual financial report and other relevant documentation for the upcoming shareholders’ meeting on July 10, 2024. This includes the annual financial report, corporate governance report, remuneration policy report, and explanatory reports on agenda items, which are accessible on the company’s website and other authorized platforms.
Antares Vision S.p.A. has released a correction regarding the explanatory report for the shareholders’ meeting scheduled for May 7, 2025. The correction pertains to the allocation of the operating result in one of the proposed resolutions, which could impact shareholder decisions and company operations.
Antares Vision S.p.A. has announced the publication of the minutes from its Board of Directors meeting held on March 25, 2025, which includes a resolution to increase share capital. The updated Articles of Association reflecting these changes are now available on the company’s website and other authorized platforms, marking a significant step in the company’s financial strategy.
Antares Vision S.p.A. has announced a shareholders’ meeting scheduled for May 7, 2025, to discuss various financial and strategic initiatives. Key agenda items include the approval of the 2024 financial statements, a new long-term stock incentive plan, and proposals for capital increases to support employee incentives, reflecting the company’s commitment to growth and stakeholder engagement.
Antares Vision Group has unveiled its 2025-2027 business plan, focusing on accelerating growth and enhancing profitability. The plan aims for a revenue growth CAGR of 7-9% and an EBITDA CAGR of 18-21%, with strategic initiatives including a commercial excellence program, cost efficiency, and cash generation. The company also plans to strengthen its market leadership, capitalize on emerging market opportunities, and implement an ESG strategy.